{"id":53567,"title":"[Timely commencement of insulin in type 2 diabetes: benefits and risks].","abstract":"Tapasztalatok szerint az inzulin bevezetése 2-es típusú diabetesben gyakran késik, jóllehet a kívánttól elmaradó anyagcserekontroll azonnali és hosszú távú következményei jól ismertek. Ez a magyarázata, hogy a korai, de legalább az id?ben megkezdett inzulinadás kezelési útmutatásokban mind nagyobb hangsúlyt kap. A közlemény áttekinti a betegség korai – els? kezelésként alkalmazott ?, illetve kés?bbi szakaszában indított inzulinadás lehetséges el?nyeit (béta-sejt-diszfunkció mérséklése, a progresszió lassítása, tartósabb és hosszú távon kedvez?bb anyagcserekontroll), valamint potenciális korlátozó tényez?it (nem kívánt vércukoresések gyakoribb el?fordulása, súlygyarapodás, romló beteg-együttm?ködés). Rámutat arra, hogy inzulin adása megfelel? kezelésválasztással a 2-es típusú diabetes minden szakaszában biztonságos terápiás alternatíva, jól igazítható az individuális glykaemiás célhoz és körültekint? betegoktatással nem rontja az érintettek életmin?ségét és nem hátráltatja hosszú távú kezelési együttm?ködésüket sem. Orv. Hetil., 2014, 155(7), 255–261.The introduction of insulin in type 2 diabetes is often too late, though the immediate as well as late consequences of inadequate metabolic control are well known. That is the reason, why a special attention is given in recent therapeutic guidelines for the importance of early, at least timely insulinisation. This review article summarizes the advantages (mitigation of the beta-cell dysfunction, long lasting good metabolic control) and potential risks (hypoglycemia, weight gain, possible deteriorating patient compliance) of early or timely insulin therapy. It is pointed out that the introduction of insulin is effective and safe therapeutic option during the whole course of type 2 diabetes, the use of different regimes is suitable to reach and maintain the individual glycemic target and, with a structured patient education, it does not disturb the quality of life and the compliance of patients.","date":"2014-02-10","categories":"Endocrine System Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/24509354","annotations":[{"name":"Hypoglycemia","weight":0.913439,"wikipedia_article":"http://en.wikipedia.org/wiki/Hypoglycemia"},{"name":"Diabetes mellitus type 2","weight":0.837917,"wikipedia_article":"http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2"},{"name":"Insulin","weight":0.822325,"wikipedia_article":"http://en.wikipedia.org/wiki/Insulin"},{"name":"Quality of life","weight":0.818686,"wikipedia_article":"http://en.wikipedia.org/wiki/Quality_of_life"},{"name":"Diabetes mellitus","weight":0.814954,"wikipedia_article":"http://en.wikipedia.org/wiki/Diabetes_mellitus"},{"name":"Therapy","weight":0.801843,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Metabolism","weight":0.762559,"wikipedia_article":"http://en.wikipedia.org/wiki/Metabolism"},{"name":"Patient","weight":0.675125,"wikipedia_article":"http://en.wikipedia.org/wiki/Patient"},{"name":"Compliance (medicine)","weight":0.415027,"wikipedia_article":"http://en.wikipedia.org/wiki/Compliance_(medicine)"},{"name":"Mental disorder","weight":0.288159,"wikipedia_article":"http://en.wikipedia.org/wiki/Mental_disorder"},{"name":"Weight gain","weight":0.279407,"wikipedia_article":"http://en.wikipedia.org/wiki/Weight_gain"},{"name":"Mind","weight":0.261381,"wikipedia_article":"http://en.wikipedia.org/wiki/Mind"},{"name":"Education","weight":0.168449,"wikipedia_article":"http://en.wikipedia.org/wiki/Education"},{"name":"Reason","weight":0.168449,"wikipedia_article":"http://en.wikipedia.org/wiki/Reason"},{"name":"Weight","weight":0.0370044,"wikipedia_article":"http://en.wikipedia.org/wiki/Weight"},{"name":"Television","weight":0.0248395,"wikipedia_article":"http://en.wikipedia.org/wiki/Television"},{"name":"Marvel Comics","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Marvel_Comics"},{"name":"1557","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/1557"},{"name":"2014","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/2014"},{"name":"Shilling","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Shilling"},{"name":"Kaph","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Kaph"},{"name":"Option (finance)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Option_(finance)"},{"name":"Review article","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Review_article"},{"name":"Glycemic index","weight":0.0156704,"wikipedia_article":"http://en.wikipedia.org/wiki/Glycemic_index"},{"name":"Graduation","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Graduation"},{"name":"Health education","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Health_education"},{"name":"Kore","weight":0.0146694,"wikipedia_article":"http://en.wikipedia.org/wiki/Kore"},{"name":"Insulin therapy","weight":0.013127,"wikipedia_article":"http://en.wikipedia.org/wiki/Insulin_therapy"}]}
